Tracks new adult medullary thyroid cancer cases over time
Records new adult thyroid cancer cases to watch for changes linked to diabetes drugs.
Plain-language title generated from the registry record
Registry title: An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Key facts
- Where
- Morgantown, United StatesSee the site
Where in United States
- United BioSource LLCMorgantown, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novo Nordisk A/S
- Trial code
- NCT01511393
- Record updated
- 13 June 2023
- Original description
This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.Read full original descriptionShow less
Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry
This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.
Inclusion: A record of medullary thyroid carcinoma (MTC) identified from state/regional population-based cancer registries; At least 18 years or older; There are no other inclusion or exclusion criteria.